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Identity 
Other names: ARD-1; ARD1; NIPP-1; NIPP1; 
PRO2047 




ARD1 is a frequently used alias for NIPP1, however, 
this name actually corresponds to an alternative 
transcript (NIPP1gamma), which encodes a truncated 
form of NIPP1 encompassing residues 225-351 only. 
This transcript has been shown to restore  
endoribonuclease activity to E. coli rne gene mutants 
(Wang and Cohen, 1994; Claverie-Martin et al., 1997; 
Chang et al., 1999; Jin et al., 1999; Van Eynde et al., 
1999). Moreover, note that the name ARD1 is also used 
for a completely unrelated protein, TRIM23 (Mishima 
et al., 1993). 
Description 
The entire PPP1R8 gene spans 20.9 kb on the forward 
strand of the long arm on chromosome 1. The gene 
contains 7 exons of which exon 1 has 5'-alternative 
splice sites. 
 
Genomic organization of the PPP1R8 gene and the alternative splice variants with their corresponding coding sequences (black line). 
Exons and alternative splice sites are indicated by different colors. 
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Transcription 
The PPP1R8 gene contains 7 exons which give rise to 5 
alternative splice products (see diagram above). 
When speaking about NIPP1, one usually refers to the 
NIPP1alpha isoform (39 kDa, 351 residues) which is 
by far the most abundant isoform in all examined 
mammalian tissues. When visualized by 
immunoblotting with C-terminal antibodies (which 
recognize all isoforms except NIPP1epsilon), also 
smaller polypeptides are visualized albeit at a much 
lower intensity as compared to the alpha-isoform. 
However, it is not clear yet whether these represent 
some of the other NIPP1 isoforms or simply 
degradation products of NIPP1alpha (Van Eynde et al., 
1999; Chang et al., 1999; Fardilha et al., 2004). 
Pseudogene 
A processed pseudogene, termed PPP1R8P, has been 
mapped to chromosome 1p33-32 (48790762-48791795 
bp from pter according to hg19 - Feb 2009). Consistent 
with this notion, it is only 1034 bp in size, contai s no 
introns and encodes an incomplete NIPP1-transcript 
due to the presence of various premature stop codons 
(Van Eynde et al., 1999). 
Protein 
Note 
Nuclear Inhibitor of PP1 (NIPP1) was first identified in 
bovine thymus nuclei as a potent inhibitor of the 
protein Ser/Thr phosphatase PP1 (Beullens et al., 1992; 
Beullens et al., 1993). Later on, it became clear th t 
NIPP1 exerts various functions in the eukaryotic cell by 
serving as a kind of scaffold protein onto which a 
variety of proteins can bind. These interaction partners 
range from protein kinase MELK, protein phosphatase 
PP1 (PPP1C-a/PPP1C-b/PPP1C-c), the pre-mRNA 
splicing factors SAP155 (SF3B1) and CDC5L to the 
chromatin modifiers EED and EZH2. 
Description 
NIPP1 consists of 351 amino acids and has a molecular 
mass of 39 kDa. However, it migrates at a size of ab ut 
45 kDa on SDS-PAGE. NIPP1 contains an N-terminal 
ForkHead Associated (FHA) domain.  
Via this established phosphothreonine-binding domain, 
NIPP1 interacts with protein kinase MELK, the 
splicing factors SAP155 and CDC5L and the histone 
methyltransferase EZH2. Moreover, it was shown that
the NIPP1 FHA-domain binds to its ligands via 
phosphorylated TP-dipeptide motifs, present in the 
interacting proteins (Boudrez et al., 2000; Boudrez et 
al., 2002; Vulsteke et al., 2004; Nuytten et al., 2008). 
Two additional interactors, PP1 and EED, have two 
separate binding sites on NIPP1: one in the central 
domain and the other at the C-terminus. In the central 
domain, the binding of NIPP1 to PP1 is mediated by a 
so called RVXF-motif, which is present in about two  
thirds of all known PP1 interacting proteins (Beullns 
et al., 1999; Beullens et al., 2000; Hendrickx et al.,
2009). In addition, the C-terminal 22 residues can 
interact with nucleic acids (Jin et al., 1999). 
Expression 
NIPP1 is ubiquitously expressed (Van Eynde et al., 
1995). 
Localisation 
NIPP1 is a nuclear protein and is enriched in splicing 
factor storage sites called speckles (Trinkle-Mulcahy et 
al., 1999; Jagiello et al., 2000). Although largely 
nuclear, some data suggest that there also exists a 
cytoplasmic pool of NIPP1 (Boudrez et al., 1999; 
Jagiello et al., 1997). 
Function 
NIPP1 is a scaffold protein and exerts its functions via 
its interacting proteins. NIPP1 was discovered as a 
potent inhibitor and a major nuclear interactor of the 
phosphatase PP1 (Beullens et al., 1999). PP1 functions 
as a holoenzyme in which the interacting proteins 
confine substrate specificity, activity and/or 
localization of PP1 (Bollen et al., 2010). For NIPP1, it 
has been shown that it acts as a physiological PP1 
inhibitor for some substrates, while functioning as an 
activator towards other substrates (Parker et al., 2002; 
Lesage et al., 2004; Comerford et al., 2006; Shi and
Manley, 2007).  
Also, the interaction between NIPP1 and PP1 can be 
regulated by phosphorylation (Beullens et al., 1993; 
Van Eynde et al., 1994; Jagiello et al., 1995; Vulsteke 
et al., 1997; Beullens et al., 1999). NIPP1 is also 
involved in 3 other major cellular processes: splicing, 
transcription and development. Firstly, NIPP1 is 
associated with spliceosomes and splicing factor 
storage sites called "speckles", probably mediated by 
its interaction with the splicing factors CDC5L and 
SAP155 (Boudrez et al., 2000; Deckert et al., 2006). 
Pre-mRNA splicing assays showed that NIPP1 is 
required for late stage spliceosome formation (Beullens 
and Bollen, 2002). Recently it was published that 
NIPP1 directs associated PP1 to dephosphorylate 
SAP155 (Tanuma et al., 2008). Secondly, NIPP1 is a 
transcriptional repressor via its interaction with EED 
and EZH2 (Jin et al., 2003; Roy et al., 2007), two core 
components of the Polycomb repressive complex 2 
(PRC2). Through its interaction with PRC2, NIPP1 
directs it to a subset of Polycomb target genes, where 
the methyltransferase EZH2 will mark genes proned for 
silencing by trimethylating histone 3 on lysine 27 
(Nuytten et al, 2008). In 2010, Van Dessel et al. 
showed that this targeting function of NIPP1 is 
dependent on associated PP1. Finally, NIPP1 is 
essential for embryonic development as a NIPP1 knock 
out mouse is embryonically lethal at the onset of 
gastrulation (Van Eynde et al., 2004). 
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A schematic representation of the domain structure of NIPP1 and its interactor binding sites. The FHA-domain (red) binds the indicated 
interactors via a phosphorylated TP dipeptide motif. NIPP1 binds PP1 via the indicated RVXF-motif and via a C-terminal binding site 
(green). EED and RNA binding sites are colored blue and orange, respectively. Known phosphorylation sites are indicated in black (in 
vivo validated) or grey (in vitro data). 
 
The splice variant NIPP1gamma or ARD1 displays a 
site-specific Mg2+-dependent endoribonuclease activity, 
in contrast to the NIPP1alpha isoform, which does not 
possess this function (Wang and Cohen, 1994; 
Claverie-Martin et al., 1997; Chang et al., 1999; Jin et 
al., 1999; Van Eynde et al., 1999). 
Homology 







An increase in NIPP1 mRNA is correlated with a 
malignant phenotype in rats (Kim et al., 2000). 
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